Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
| Revenue (TTM) | $5.36B |
| Gross Profit (TTM) | $1.72B |
| EBITDA | $1.16B |
| Operating Margin | 3.32% |
| Return on Equity | -1.75% |
| Return on Assets | 0.80% |
| Revenue/Share (TTM) | $23.54 |
| Book Value | $35.61 |
| Price-to-Book | 1.24 |
| Price-to-Sales (TTM) | 2.02 |
| EV/Revenue | 3.359 |
| EV/EBITDA | 16.64 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.40% |
| Shares Outstanding | $227.67M |
| Float | $57.75M |
| % Insiders | 68.46% |
| % Institutions | 34.95% |
Volatility is currently contracting
Lineage remains a Buy, offering a margin of safety and re-rating potential despite near-term macro and operational headwinds. Q1 saw AFFO per share decline 9.3% to $0.78, but guidance for Adj. EBITDA ($1.25–$1.3B) and AFFO per share ($2.75–$3.00) were maintained. LINE's cost reduction plan and automation investments target $110M annualized EBITDA improvement in 3–5 years, supporting long-term upside.
NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE), announced that it will report its financial results for the second quarter of 2026 on Wednesday, August 5, 2026, before market open. A conference call to discuss these results has been scheduled for 8:00 a.m. Eastern Time on Wednesday, August 5, 2026. A live webcast of the call will be available on the Lineage Investor Relations website at ir.onelineage.com. An audio replay of the conference call will be available for one week followin.
REITs are poised for 6-7% earnings growth in coming years, outpacing the historical 3-4% average, with multiple sectors showing accelerating fundamentals. Shopping centers, healthcare (notably senior housing), and data centers are standout sectors, benefiting from robust private market demand, supply constraints, and AI-driven tailwinds. Office REITs see improving leasing, especially from AI-related demand, while quality bifurcation widens; overweight positions in BXP and CUZ reflect this thesis.
Lineage Logistics faces significant operational and financial risks after two catastrophic fires at major cold storage facilities. Recent fires have led to lawsuits, public health concerns, and potential long-term brand damage, particularly in Los Angeles. Immediate costs include emergency relief and remediation, while longer-term impacts may include higher insurance premiums and increased operating expenses.
NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced that its Board of Directors has declared a cash dividend of $0.5325 per share for the second quarter of 2026. The dividend will be paid on July 21, 2026, to shareholders of record of the Company's common stock as of the close of business on June 30, 2026. About Lineage Lineage, Inc. (NASDAQ: LINE) is the world's largest global temperature-.
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Lineage, Inc. (NASDAQ: LINE) breached their fiduciary duties to shareholders.
Lineage, the largest cold storage REIT, currently trades at 25% above recent lows, but 50% below the 2024 IPO price. With 24,000 employees, headcount intensity is 20-100x that of typical industrial REITs. Adoption of humanoid robots as the next step in LINE's automation strategy could dramatically reduce headcount and improve financial results.
Lineage, Inc. (LINE) Q1 2026 Earnings Call Transcript
Lineage, Inc. (LINE) came out with quarterly funds from operations (FFO) of $0.78 per share, beating the Zacks Consensus Estimate of $0.7 per share. This compares to FFO of $0.86 per share a year ago.
NEW YORK, April 20, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Lineage, Inc. (NASDAQ: LINE) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Lineage caused the company to misrepresent or fail to disclose that Lineage's financial and operational results had been temporarily inflated leading up to the IPO as a result of artificial market distortions caused by the COVID-19 pandemic, increased supply of cold-storage facilities, and the imposition of unsustainable price increases by Lineage.
